D-0439-2026 Class II Ongoing

Recalled by Fagron Compounding Services — Wichita, KS

FDA drug recall D-0439-2026 was initiated by Fagron Compounding Services on Mar 20, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port The recall status is ongoing. Affected quantity: 5140 bags.

Recall details

Product Type
Drugs
Report Date
Apr 15, 2026
Initiation Date
Mar 20, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5140 bags

Product description

norepinephrine Bitartrate, 32mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5027-02

Reason for recall

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Distribution pattern

Nationwide in the U.S.A.

Code information

Lot: C274-000050004, Exp.: 4/24/2026; C274-000050295, Exp.:5/8/2026; C274-000050773, Exp.: 6/4/2026; C274-000051219, Exp.: 6/21/2026; C274-000051318, Exp.: 6/27/2026; C274-000051602, Exp.: 7/12/2026.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0439-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0439-2026. Report a data issue: hello@regdatalab.com.